Smoking Cessation and the Risk for Type 2 Diabetes Mellitus
Authors: Altan Onat
Journal: Annals of Internal Medicine (2010)

Letters1 June 2010Smoking Cessation and the Risk for Type 2 Diabetes MellitusAltan Onat, MDAltan Onat, MDFrom Istanbul University, 34452 Istanbul, Turkey.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-152-11-201006010-00019 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Yeh and colleagues (1) prospectively examined the association of smoking status with development of incident type 2 diabetes in the ARIC (Atherosclerosis Risk in Communities) cohort (1) and concluded that predicts incident diabetes and that cessation leads to higher short-term risk. The first part of the conclusion was not convincing for several reasons.First, excess risk did not emerge in one third of the smokers (mild smokers). Second, the study does not clarify whether this risk is valid only for men or for both sexes, because sex-stratified analyses are missing. In the regression analyses, the referent never-smokers ...References1. Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152:10-7. [PMID: 20048267] LinkGoogle Scholar2. Onat A, Ozhan H, Esen AM, Albayrak S, Karabulut A, Can G, et al. Prospective epidemiologic evidence of a “protective” effect of smoking on metabolic syndrome and diabetes among Turkish women—without associated overall health benefit. Atherosclerosis. 2007;193:380-8. [PMID: 16926017] CrossrefMedlineGoogle Scholar3. Nagaya T, Yoshida H, Takahashi H, Kawai M. Heavy smoking raises risk for type 2 diabetes mellitus in obese men; but, light smoking reduces the risk in lean men: a follow-up study in Japan. Ann Epidemiol. 2008;18:113-8. [PMID: 18083537] CrossrefMedlineGoogle Scholar4. Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30:325-31. [PMID: 17259502] CrossrefMedlineGoogle Scholar5. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al; Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132-40. [PMID: 20031199] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Istanbul University, 34452 Istanbul, Turkey.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSmoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus Hsin-Chieh Yeh , Bruce B. Duncan , Maria Inês Schmidt , Nae-Yuh Wang , and Frederick L. Brancati Smoking Cessation and the Risk for Type 2 Diabetes Mellitus Richard L. Shriner , Noni A. Graham , and Mark S. Gold Smoking Cessation and the Risk for Type 2 Diabetes Mellitus Hsin-Chieh Yeh and Frederick L. Brancati Smoking Cessation and the Risk for Type 2 Diabetes Mellitus Roy C. Ziegelstein Metrics Cited ByRelationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis 1 June 2010Volume 152, Issue 11Page: 754-755KeywordsBody mass indexC-reactive proteinsHabitsInsulin resistanceMedical risk factorsObesityRegression analysisType 2 diabetes ePublished: 1 June 2010 Issue Published: 1 June 2010 CopyrightCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...